Skip to content
Cartherics Logo Cartherics Logo
  • Our Company
    • About Us
    • Our Vision & Mission
    • Founders
    • Board Members & Key Executives
    • Scientific Consultants
    • Partners & Collaborations
    • Our Lab
  • Technology
    • Our Technology
  • Pipeline
    • Our Pipeline
    • Scientific Publications
    • Scientific & Company Presentations
  • Careers
    • Careers at Cartherics
    • Education Opportunities
  • Latest News
  • Investors
  • Contact Us

Latest News

Home » Latest News
Latest Newscarth_admin2026-06-02T11:12:27+10:00
  • Categories: General Investor News

    UC San Diego Health Treats 1st Cancer Patient with Stem-Cell Derived Natural Killer Cells

    Published On: April 2nd, 2019

    https://health.ucsd.edu/news/releases/Pages/2019-04-01-UC-San-Diego-Health-Treats-Cancer-Patient-with-Stem-Cell-Derived-Natural-Killer-Cells.aspx UC San Diego Health Treats 1st Cancer Patient with Stem-Cell Derived Natural Killer Cells Fate Therapeutics, in collaboration with [...]

    Read More
  • Categories: General Investor News

    Tom’s Long Fight

    Published On: March 25th, 2019

    Tom Long's battle with Multiple Myeloma Lisa Wilkinson interviewed Aussie Actor and multiple myeloma patient Tom Long on The Sunday [...]

    Read More
  • Categories: General The Pipeline

    From Bangladesh to Melbourne …… via Perth

    Published On: March 25th, 2019

    Ms Rasa Islam is Cartherics’ first full-time PhD student. She’s joining the team under a prestigious Cooperative Research Centre (CRC) [...]

    Read More
  • Categories: General Investor News

    Australia is handicapped in the delivery of cell therapies, says Alan Trounson

    Published On: March 21st, 2019

    THE promise is remarkable: a new class of affordable, effective cancer treatments beyond surgery, chemotherapy, biologicals and radiation. Imagine cancer [...]

    Read More
  • Categories: General Investor News

    Safer cells for immunotherapy

    Published On: February 13th, 2019

    Cartherics Pty Ltd teams up with Canada's panCELLa Inc to bring the power of safe cell therapy to a greater [...]

    Read More
  • Categories: General

    Eradicate Cancer 2020 – Next frontiers in immunotherapy

    Published On: January 29th, 2019

    Melbourne Convention and Exhibition Centre, 25-27 March 2020 "Success Breeds Success" The field of immunotherapy against cancers is making unprecedented [...]

    Read More
  • Categories: General Investor News

    Biotech Daily: Cartherics, ToolGen …. Gene-Edit Stem Cells for Cancer Immunotherapies

    Published On: January 23rd, 2019

    BD Biotech Daily Jan 23 - Cartherics

    Read More
  • Categories: General Investor News

    SUPER-CHARGING THE IMMUNE SYSTEM TO FIGHT CANCER

    Published On: January 21st, 2019

    Innovative immunotherapies for cancer are a step closer to reality thanks to an agreement between Australia’s Cartherics Pty Ltd and [...]

    Read More
  • Categories: General Investor News

    New cancer immunotherapy approach turns immune cells into tiny anti-tumor drug factories

    Published On: December 20th, 2018

    https://www.eurekalert.org/pub_releases/2018-12/uoc--nci120418.php In lab and mouse experiments, UC San Diego School of Medicine researchers developed a method to leverage B cells [...]

    Read More
  • Categories: General Investor News

    ‘Revolutionary’ cancer drug using genetically modified cells approved (Kymriah)

    Published On: December 19th, 2018

    Sydney Morning Herald (By Esther Han) 19 December 2018 — 12:00am https://www.smh.com.au/national/revolutionary-cancer-drug-using-genetically-modified-cells-approved-20181217-p50msk.html A revolutionary cancer therapy that supercharges a patient's [...]

    Read More
  • Categories: General The Pipeline

    Meet our newest recruit

    Published On: December 18th, 2018

    Research Assistant Callum Docherty explains why immunology is his passion and advancing cancer therapy is his goal. I’ve always had [...]

    Read More
  • Categories: General The Pipeline

    Come Hell Or High Water

    Published On: December 4th, 2018

    Cartherics Communications Adviser Leigh Dayton reveals the lengths Cartherics co-founder and immunologist Richard Boyd will go to for a good [...]

    Read More
  • Categories: General Investor News

    The Beautiful Cure’ Reveals The ‘Profound’ Power Of The Immune System

    Published On: November 29th, 2018

    An interview with UK immunologist Daniel Davis on national Public Radio's "Fresh Air" is a good discussion about his new [...]

    Read More
  • Categories: General The Pipeline

    Cartherics Corporate Adviser Dr Ian Nisbet talks about ‘what pisses him off’

    Published On: November 22nd, 2018

    WHAT PISSES ME OFF When it comes to taking ideas to market, Corporate Advisor Ian Nisbet says America’s entrepreneurial ethos [...]

    Read More
  • Categories: General Investor News The Pipeline

    Communications Adviser Leigh Dayton talks to Cartherics Scientific Board member Jacques Miller – the man who discovered the function of the thymus gland yet didn’t win the Nobel Prize.

    Published On: November 9th, 2018

    IMMUNOLOGIST Jacques Miller did not win this year’s Nobel Prize in Physiology or Medicine. He didn’t win it last year [...]

    Read More
Previous131415Next
  • Our Company
  • Technology
  • Pipeline
  • Latest News
  • Investors

12 Ferntree Place
Notting Hill VIC 3168
AUSTRALIA

info@cartherics.com

+61 1300 973 415

About us

Cartherics’ mission is the development of novel, immune cell therapy products for the treatment of cancer and endometriosis.

Sign up to our newsletter

Stay informed about our latest news and developments

* indicates required


© Copyright 2022 – 2026| Cartherics Pty Ltd

Page load link

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Cartherics
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Analytics

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Go to Top